Jci_page_head_homepage_01 Jci_page_head_homepage_02
Marcus Maurer, Wolfgang Seidel-Guyenot, Martin Metz, Juergen Knop, Kerstin Steinbrink
Published in Volume 112, Issue 3
J Clin Invest. 2003; 112(3):432–439 doi:10.1172/JCI18106
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

Exogenous IL-10 improves the development of tolerance to contact allergen. Ear-swelling responses after sensitization and challenge with TNCB in normal mice that had been treated with IL-10 (intraperitoneal injection of 100 ng per mouse three times a day) or vehicle during low zone tolerization. Data represent absolute (a) and relative (b) changes in ear thickness (means ± SEM pooled from six or more mice per treatment group from one of three independent experiments with similar results). **P < 0.01; *P < 0.05 for IL-10–treated versus vehicle-treated animals.